Chronic motor axonal neuropathy associated with antibodies monospecific for n-acetylgalactosaminyl GD1a
✍ Scribed by Ryuji Kaji; Susumu Kusunoki; Kotaro Mizutani; Nobuyuki Oka; Yasuhiro Kojima; Nobuo Kohara; Jun Kimura
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 237 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0148-639X
No coin nor oath required. For personal study only.
✦ Synopsis
We report on three patients with chronic motor neuropathy who had elevated titers of immunoglobulin (Ig)G antibodies against Nacetylgalactosaminyl GD1a (GalNAc-GD1a) and normal titers of antibodies against other gangliosides. Presenting with progressive muscular atrophy, fasciculations, and no sensory deficits, the patients had been diagnosed to have motor neuron disease. Electrodiagnostic features were predominantly axonal. Two patients clinically improved after intravenous Ig infusion and cyclophosphamide therapy. Increased titers of IgM antibodies to GalNAc-GD1a were also found in two of 15 patients with multifocal motor neuropathy with conduction block but were associated with concomitant rise of anti-GM1 antibodies. These three cases represent a chronic motor axonal neuropathy in which antibody testing for a minor ganglioside was helpful for instituting therapy.